000 01348 a2200421 4500
005 20250517205049.0
264 0 _c20191115
008 201911s 0 0 eng d
022 _a1756-8722
024 7 _a10.1186/s13045-018-0584-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShi, Cunzhen
245 0 0 _aThe proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma.
_h[electronic resource]
260 _bJournal of hematology & oncology
_c03 2018
300 _a43 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLymphoma, Mantle-Cell
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred NOD
650 0 4 _aMice, SCID
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aProto-Oncogene Mas
650 0 4 _aSurvival Analysis
700 1 _aLi, Xiangqun
700 1 _aWang, Xiaogan
700 1 _aDing, Ning
700 1 _aPing, Lingyan
700 1 _aShi, Yunfei
700 1 _aMi, Lan
700 1 _aLai, Yumei
700 1 _aSong, Yuqin
700 1 _aZhu, Jun
773 0 _tJournal of hematology & oncology
_gvol. 11
_gno. 1
_gp. 43
856 4 0 _uhttps://doi.org/10.1186/s13045-018-0584-6
_zAvailable from publisher's website
999 _c28194322
_d28194322